What is IrsiCaixa?

The IrsiCaixa Institute for AIDS Research is an internationally-recognized oraganization with the aim of contributing to improving understanding of the disease, its prevention and treatments of HIV and AIDS with the ultimate goal of eradicating the epidemic.

It was founded in 1995 as a prívate non-profit making foundation by the Fundació La Caixa and the Department of Health of the autonomous Catalan government, and is located at the Germans Triuas i Pujol Hospital in Badalona.

Directed by Dr Bonaventura Clotet, IrsiCaixa consists of over 50 researchers who focus their activities on basic research into understanding HIV infection mechanisms and developing new therapies and vaccines. At the same time, the foundation participates in clinical studies to evaluate new therapeutic strategies, and cooperate with developing countries, collaborating in the fight against the pandemic on a global scale.

The IrsiCaixa Institute for AIDS Research IRSI Caixa works alongside the most prestigious international research centres, and its publications are among those with the most impact in their field.

Our mission

Carry out, promote and divulge biomedical research in the field of Health Sciences and Epidemiology, especially in the area of Acquired Immune Deficiency Syndrome (AIDS) and its etiological agent, the Human Immunodeficiency Virus (HIV).


Develop outstanding, internationally recognized research into HIV / AIDS in order to contribute to improving understanding, prevention and treatments if the disease.

Provide research results to health sector professionals and patients so they benefit directly, as well as society in general to contribute to the prevention of AIDS.

IrsiCaixa currently consists of 7 research groups which work in the following areas:

  1. Basic research: with the objective of contributing to the understanding of HIV infection mechanisms and identifying new therapeutic targets.
  2. Clinical research: to evaluate new therapeutic strategies.
  3. Research into vaccines: to develop a preventative, therapeutic vaccine against HIV.
  4. Research in developing countries to assist them in their research tasks.